Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Di Domenico

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Antioxidants & Redox Signaling|September 15, 2016
The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox ProteomicsFabio Di Domenico, Eugenio Barone, Marzia Perluigi, et al.
Free Radical Biology & Medicine|September 16, 2021
The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer diseaseEugenio Barone, Fabio Di Domenico, Marzia Perluigi, et al.
Antioxidants (Basel, Switzerland)|May 4, 2026
Loss of Proteostasis and Early-Onset Neurodegeneration in Down Syndrome: From Mechanisms to InterventionsAntonella Tramutola, Chiara Lanzillotta, Fabio Di Domenico, et al.
Oxidative Medicine and Cellular Longevity|February 17, 2016
It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer DiseaseAntonella Tramutola, Fabio Di Domenico, Eugenio Barone, et al.
Mass Spectrometry Reviews|June 17, 2014
Mass spectrometry and redox proteomics: applications in diseaseD Allan Butterfield, Liqing Gu, Fabio Di Domenico, et al.
Neuro-Degenerative Diseases|November 26, 2015
Increased Mammalian Target of Rapamycin Signaling Contributes to the Accumulation of Protein Oxidative Damage in a Mouse Model of Down's SyndromeAntonella Tramutola, Chiara Lanzillotta, Andrea Arena, et al.
The Biochemical Journal|September 23, 2014
Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brainD Allan Butterfield, Fabio Di Domenico, Aaron M Swomley, et al.
Free Radical Biology & Medicine|August 16, 2017
mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementiaFabio Di Domenico, Antonella Tramutola, Cesira Foppoli, et al.
Free Radical Biology & Medicine|May 3, 2012
Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairmentEugenio Barone, Fabio Di Domenico, Rukhsana Sultana, et al.
Neurobiology of Disease|January 29, 2020
Brain insulin resistance triggers early onset Alzheimer disease in Down syndromeAntonella Tramutola, Chiara Lanzillotta, Fabio Di Domenico, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Antioxidants & Redox Signaling|September 15, 2016
The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox ProteomicsFabio Di Domenico, Eugenio Barone, Marzia Perluigi, et al.
Free Radical Biology & Medicine|September 16, 2021
The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer diseaseEugenio Barone, Fabio Di Domenico, Marzia Perluigi, et al.
Antioxidants (Basel, Switzerland)|May 4, 2026
Loss of Proteostasis and Early-Onset Neurodegeneration in Down Syndrome: From Mechanisms to InterventionsAntonella Tramutola, Chiara Lanzillotta, Fabio Di Domenico, et al.
Oxidative Medicine and Cellular Longevity|February 17, 2016
It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer DiseaseAntonella Tramutola, Fabio Di Domenico, Eugenio Barone, et al.
Mass Spectrometry Reviews|June 17, 2014
Mass spectrometry and redox proteomics: applications in diseaseD Allan Butterfield, Liqing Gu, Fabio Di Domenico, et al.
Neuro-Degenerative Diseases|November 26, 2015
Increased Mammalian Target of Rapamycin Signaling Contributes to the Accumulation of Protein Oxidative Damage in a Mouse Model of Down's SyndromeAntonella Tramutola, Chiara Lanzillotta, Andrea Arena, et al.
The Biochemical Journal|September 23, 2014
Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brainD Allan Butterfield, Fabio Di Domenico, Aaron M Swomley, et al.
Free Radical Biology & Medicine|August 16, 2017
mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementiaFabio Di Domenico, Antonella Tramutola, Cesira Foppoli, et al.
Free Radical Biology & Medicine|May 3, 2012
Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairmentEugenio Barone, Fabio Di Domenico, Rukhsana Sultana, et al.
Neurobiology of Disease|January 29, 2020
Brain insulin resistance triggers early onset Alzheimer disease in Down syndromeAntonella Tramutola, Chiara Lanzillotta, Fabio Di Domenico, et al.
Pageof 11